Tau can be measured in CSF as total tau (t-tau), which is increased in AD and in several other neurologic diseases, or as p-tau, which is more specifically increased in AD.1 PET tracers have made it possible to visualize and quantify tau deposits in vivo. This evidence concerns the gene MAPT and Alzheimer disease.